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OBJECTIVES We sought to validate the ability of real-time myocardial contrast echocardiography (MCE)
measures of opacification defect and contrast refilling parameters to estimate risk area (RA)
and infarct area (IA) during coronary occlusion and reperfusion.
BACKGROUND No data exist establishing the accuracy of MCE in determining RA and IA size. We
hypothesized that in the setting of coronary occlusion, MCE should identify RA as a
perfusion defect early after bubble destruction, collateral flow to viable myocardium as
opacification late during refilling and IA as absent opacification.
METHODS Three hours of coronary occlusion and reperfusion were each produced in 11 dogs in which
real-time MCE was performed during intravenous infusion of Sonovue (Bracco). Real-time
contrast echocardiography was performed at baseline, during occlusion and reperfusion. Early
(BEGIN) and end (END) images from a FLASH refilling sequence were acquired, as well
as late refilling images (LATE) 1 min after FLASH. Real-time contrast echocardiography
defect size and quantitative refilling parameters were compared with RA and IA determined
by tissue staining.
RESULTS During occlusion, defect size varied with refilling time; defects from BEGIN images
correlated best to RA and those from LATE images to IA. Refilling parameters, but not
LATE peak intensity, did not predict the IA size during occlusion. During reperfusion,
defects from BEGIN images were well correlated to RA and END images to IA, whereas
peak plateau intensity and refilling slope parameters predicted IA size.
CONCLUSIONS Real-time contrast echocardiography defect size varies throughout microbubble refilling.
Appropriately selected defect sizes and refilling parameters provide estimates of RA and IA
during coronary occlusion and reperfusion. (J Am Coll Cardiol 2002;39:1546–54) © 2002
by the American College of Cardiology Foundation
Low energy real-time myocardial contrast echocardiography
(MCE) permits quantitative analysis of myocardial blood
flow (MBF) from the rate of intensity increase produced by
microbubbles entering an imaging field after a high energy
impulse that caused bubble destruction (1). Specifically, the
rate of intensity increase and the peak plateau signal
intensity provide parameters that represent MBF velocity
and microcirculatory cross-sectional volume, respectively
(2). Previous studies have demonstrated that the measure-
ment of contrast reappearance can detect reduced blood
flow velocity due to coronary stenoses (3). Although prior
studies have shown the effects of collateral flow on MCE
perfusion defects (4), no data exist regarding the value of
contrast microbubble refilling dynamics in assessing the risk
area (RA) and infarct area (IA) associated with total
coronary occlusion. Neither are any data available regarding
the ability of the MCE blood flow parameters of peak
plateau intensity and refilling rate to assess final infarct size
when acquired during occlusion and reperfusion.
Because adequate collateral flow is known to prevent
myocardial necrosis despite an occluded epicardial coronary
artery, quantitative analysis of the presence and time course
of opacification of the perfusion bed of an occluded artery
should enable identification of RA and infarcted myocar-
dium. We hypothesized that in coronary occlusion, MCE
should identify the total area of myocardium at risk as a
perfusion defect early after bubble destruction. Within this
area, myocardium subserved by collateral flow should be
recognized as opacification occurring late during refilling,
and infarcted nonviable muscle as that without detectable
contrast intensity.
Therefore, the current study employed in-vivo experi-
ments: 1) to validate the ability of low energy, real-time
MCE to estimate RA and infarct size, and 2) to define the
capability of quantitative parameters derived from MCE
refilling curves to predict the size of the IA.
METHODS
Animal preparation. Eleven open-chest mongrel dogs
were subjected to 3 h of coronary occlusion followed by 3 h
of reperfusion in accordance with the “Position of the
American Heart Association on Research Animal Use.” A
lateral thoracotomy was performed and the heart was
suspended in a pericardial cradle. An occluder was placed
around either the proximal left anterior descending (nine
animals) or circumflex (two animals) coronary branch and
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an ultrasonic transit-time flow probe (2.0 to 2.5 mm) was
positioned proximal to the occluder and connected to a
flow-meter (model T201; Transonic System Inc., Ithaca,
New York). Three 7F catheters were placed: left femoral
artery for withdrawal of reference samples for blood flow
measurements, right femoral artery to record arterial pres-
sure and left femoral vein to infuse drugs and fluids. A
catheter (Swan-Ganz) monitored pulmonary artery pres-
sures and measured wedge pressure.
Myocardial contrast echocardiography was performed
with a real-time ultrasound system (HDI5000, ATL, Both-
ell, Washington) capable of low energy (0.13 to 0.15
mechanical index) MCE. Short-axis midpapillary muscle
images were obtained with the transducer fixed on a
saline-filled latex bag positioned on the left ventricular
anterior wall. Instrument settings were optimized and held
constant for each dog. Sonovue (Bracco Inc., Milano, Italia)
was continuously infused at a rate of 30 ml/h by a gently
agitated infusion pump. Two successive real-time sequences
were recorded: the first was a FLASH sequence, consisting
of 15 cardiac cycles (maximum buffer memory allowed)
initiated by three high energy (1.0 MI) transmission images,
which produced bubble destruction and enabled visualiza-
tion of subsequent refilling. The second (LATE) sequence
was also acquired during real-time mode and consisted of
five cardiac cycles recorded 1 and 2 min after FLASH
transmission. From these sequences, end-systolic images
were carefully selected for subsequent quantitative analysis
to avoid motion artifacts.
Image analysis. Sequences were acquired during occlusion
and reperfusion and were compared to baseline to identify
perfusion abnormalities. After pictures were transferred to
commercial image analysis software, the borders of perfu-
sion defects were visually identified as the largest area with
clearly diminished opacification and the area measured by
digital planimetry by two observers blind to conditions. The
images from four real-time phases were specifically analyzed
and compared with each other: 1) the initial two to four
cardiac cycles following FLASH transmission (BEGIN), 2)
the final two to four refilling cardiac cycles at the end of the
15-cycle FLASH refilling sequence (END) and five cardiac
cycles at 1 and 2 min after the FLASH transmission
(LATE) (Fig. 1). Defect size was expressed as the percent of
the total planed myocardial area from the same image.
Refilling parameter calculation. The raw data were ana-
lyzed using HDI Lab (ATL) software. Two equal-sized
regions of interest were manually traced in the mid-wall
myocardium: one including the defect from BEGIN and
one in the center of a comparable adjacent area without
visualized defect (control area, CA). The region of interest
was drawn to encompass nearly the entire BEGIN defect
with the exclusion of high intensity endocardial and epicar-
dial borders. Myocardial contrast echocardiography inten-
sity throughout the FLASH imaging sequence was plotted
against time and fitted to the exponential function (y 
A(1  ebt)  c), where A was the plateau signal intensity
reflecting the cross-sectional blood volume, b the rate of rise
to the plateau reflecting myocardial blood velocity and c the
intercept at the origin (2). Consequently, the product of A
and b reflected the volume of MBF. From the late se-
quences, we averaged the peak signal intensity from five
end-systolic pictures.
MBF measurement and dye analysis. Myocardial blood
flow was measured by standard techniques. Briefly, fluores-
cent microspheres were injected into the left atrium while
reference blood samples were withdrawn from the femoral
artery. At the end of the experiment, the coronary artery was
reoccluded, blue dye was injected in the left atrium and the
RA myocardium was delineated as that without blue stain.
Abbreviations and Acronyms
BEGIN  beginning of the FLASH sequence
CA  control area
END  end of the FLASH sequence
IA  infarct area
LATE  late sequence
MBF  myocardial blood flow
MCE  myocardial contrast echocardiography
RA  risk area
Figure 1. Diagram summarizing FLASH and LATE sequence protocol performed during occlusion and reperfusion. MCE  myocardial contract
echocardiography.
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Following the insertion of needles for identification, the
myocardial cross-section corresponding to the echo short-
axis image was acquired and divided in two. One-half was
incubated in a 2% solution of 2,3,5-triphenyltetrazolium
chloride (TTC) for 20 min at 37°C, and the infarcted
myocardium was identified as the region that failed to
demonstrate brisk red staining. This slice was then photo-
graphed in color and the outlines of the entire cross-section,
the RA, and the infarct zone were measured by digital
planimetry. The second slice was cut into 10 equal-sized
wedge-shaped transmural samples for MBF analysis using a
flow cytometer to count the entrapped microspheres.
Experimental protocol. Hemodynamics, MBF, flow-
meter measurements and real-time MCE were acquired at
baseline for each animal. Coronary occlusion was then
performed for 3 h. For the initial four experiments, mea-
surements were obtained at 90 min of occlusion and just
before reperfusion at 180 min. Because these values were
similar, all subsequent measurements obtained and reported
were performed at 90 min occlusion. Reperfusion was then
implemented and measurements repeated at 30, 60, 120 and
180 min following reflow.
Statistical methods. Data were expressed as mean  SD.
Comparison of hemodynamics, MBF and MCE data was
performed using repeated-measures analysis of variance and
Student t test. Defect sizes by MCE were correlated with
those by blue dye and TTC. A value of p  0.05 (two-
sided) was considered significant except for multiple com-
parisons concerning A and b values; these two parameters
were assessed five times with baseline, so we applied the
Bonferroni’s correction to the threshold of significance.
Consequently, the significance was set to 0.01. Reproduc-
ibility of measurements was assessed by analysis of variance.
RESULTS
The protocol was successfully performed in all 11 dogs. Two
dogs had ventricular fibrillation during occlusion, which
required external electric shock, but hemodynamics were
subsequently stabilized afterward. High-quality contrast
images with minimum artifacts were obtained during base-
line, occlusion and reperfusion, and successful FLASH
imaging was carried out, which produced profound micro-
bubble destruction. Hemodynamic data for the entire study
group are presented in Table 1. The mean RA of the study
population was 32 8% and the mean infarct size was 20
13% of the left ventricle. At each time point during
occlusion and reperfusion, MCE parameters (A and b)
correlated with flow measurements obtained from micro-
spheres (RA/CA MCE vs. MBF: y  1.92x 0.35, r 
0.66, p  0.05). Myocardial contrast echocardiography
consistently underestimated IA at all time points.
Assessment of risk and IAs during occlusion. Analysis of
FLASH sequences acquired during occlusion demonstrated
a clear area of decreased opacification in the perfusion bed of
the occluded coronary (Fig. 2). The defect size was similar
throughout the FLASH sequence (BEGIN: 35  8%,
END: 32  11%, p  ns). The tendency for defect size to
decrease during the sequence may have been related to more
complete filling of the border zone at the end of the
sequence. Alternatively, signal intensity in the CA was
increased from BEGIN to END (3.4  1.1 dB vs. 6.9 
1.8 dB, p 0.05) yielding better visualization and definition
of defects in the final cycles of the sequence. As opposed to
the FLASH sequence, opacification defects from LATE
images (1 min after FLASH sequence) were significantly
smaller than either BEGIN or END (LATE: 18  11%,
p  0.001) (Fig. 2), indicating that 15 cardiac cycles were
insufficient to achieve complete RA perfusion. However, no
significant difference was observed between LATE at 1 and
2 min, either in terms of defect measurements (18  11%
vs. 20  9%, p  ns) or signal intensity (3.29  1.72 dB vs.
3.38  1.97 dB, p  ns), demonstrating that during
occlusion steady-state MCE reperfusion in the RA was
reached by 1 min.
Comparison with postmortem analysis established that
both BEGIN and END defect size and blue dye RA sizes
were closely correlated (y 0.80x 0.09, r 0.84, and y
0.75x  0.05, r  0.79). However, both BEGIN and END
defect sizes correlated less closely with IA size by TTC (y
0.34x  0.13, r  0.61, and y  0.40x  0.26, r  0.69).
Conversely, the correlation between LATE defects and IA
sizes was closer than the correlation between LATE defect
and RA sizes (y  0.76x  0.03, r  0.86 for IA vs. y 
0.90x  0.10, r  0.61 for RA) (Fig. 3). Thus, during
occlusion FLASH and LATE sequences differed in the
significance of defect sizes. FLASH sequence defect size
more closely reflected RA, whereas LATE sequence defect
size provided a more accurate assessment of the IA.
Measurement of MCE signal during occlusion (Fig.
4). Within the RA, peak plateau intensity (A), refilling
slope (b) and product A  b from the FLASH sequence
were 5.88 1.21 dB, 0.28 0.12 s1 and 1.64 1.10 dB.s1
at baseline, and decreased during occlusion to 1.34 0.86 dB,
0.05  0.03 s1 and 0.067  0.068 dB.s1, respectively.
Table 1. Hemodynamic Data
Baseline Occl. R30 R60 R120 R180
HR (beats/min) 131  13 122  11 121  9 120  9 115  8* 120  15
SBP (mm Hg) 136  16 133  21 123  26 123  17 122  24 114  18*
DBP (mm Hg) 106  14 108  17 95  20* 94  11* 94  16* 88  11*
WP (mm Hg) 10.8  1.1 13.4  4* 14.8  3* 14.7  4* 14.7  3* 14.4  3*
CF (ml/mn) 16  6 0  0* 16  5 17  7 16  9 12  5*
CF  coronary flow; DBP  diastolic blood pressure; HR  heart rate; SBP  systolic blood pressure; WP  wedge pressure.
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During occlusion, the peak intensity plateau (A) value
measured from LATE was significantly higher than from
the FLASH sequence (3.29  1.72 dB vs. 1.34  0.86 dB,
p  0.005). Furthermore, the correlation between A from
LATE and IA size was significantly closer than that with A,
b and product A  b from the FLASH sequence (y 
10.7x  5.4, r  0.81, vs. y  2.51x  1.8, r  0.37,
y  0.23x  0.12, r  0.36 and y  0.42x  0.16, r 
0.51, respectively, p  0.05) (Fig. 4). Thus, peak plateau
intensity from LATE, which is assumed to be due to
collateral flow, showed a good correlation to the final IA,
confirming data from defect size measurements.
Assessment of reperfused and IAs during reperfusion.
Following reperfusion, opacification defects continued to be
observed in 10 of 11 animals at END, although the defect
in one animal was so small as to be nearly immeasurable. As
with occlusion, we compared images from FLASH and
LATE sequences during reperfusion. As opposed to occlu-
sion, during reperfusion no difference was observed between
END and LATE in either the size or signal intensity of the
opacification defects (Fig. 2). For example, at the 60-min
reperfusion measurement, defect sizes were 28  9% from
END and 27  7% from LATE 1 min (p  ns). Similarly,
signal intensities were 4.7  1.9 and 4.9  1.4 dB in
reperfused area with END and LATE respectively (p ns).
Conversely, comparison clearly revealed marked differences
in BEGIN and END defect measurements during reperfu-
sion. Mean defect size was 28  14%, 28  9%, 32  9%
and 31  8% at 30, 60, 120 and 180 min of reperfusion at
BEGIN and 14  13%, 13  14%, 16  13% and 17 
12% at END, all p  0.01. No significant difference was
observed between either mean defect size from BEGIN and
reperfused area size or mean defect size from END and IA
size (for example, at 180 min of reperfusion: BEGIN 31 
8% vs. RA 32  8%, p  ns and BEGIN 31  8% vs. IA
20 13%, p 0.05, and END 17 12% vs. RA 32 8%,
p  0.05, and END17  12% vs. IA 20  13%, p  ns).
Regression analysis performed between BEGIN and RA
and between END and IA yielded correlation coefficients
during reperfusion, as shown in Figure 5. BEGIN corre-
lated closely with RA at all time points, whereas END
correlated closely with IA. The correlation was weakest
Figure 2. Representative myocardial contrast echocardiography images and tissue sample delineating risk area and infarct size during occlusion (top) and
reperfusion (middle). With occlusion, opacification defect was unchanged throughout FLASH and related best to risk area (RA), but smaller in LATE
phase and related best to infarct area (IA). With reperfusion, BEGIN FLASH was larger and related best to RA, whereas END FLASH was similar to
LATE images and best reflected IA.
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between BEGIN and RA at 30 min of reperfusion (r 
0.34) and strongest between END and IA at 180 min (r 
0.93).
Quantitative MCE parameters during reperfusion (Fig.
6). A and b parameters from the FLASH sequence were
decreased compared to baseline and control during reperfu-
sion, with statistically significant reductions observed at 120
and 180 min for the A parameter and at all reperfusion
stages for the b parameter (Fig. 6). In the subgroup of three
animals with large infarctions of at least 80% of the RA, we
observed a marked decrease of A and b parameters at 30 min
of reperfusion, which did not subsequently vary with addi-
tional reperfusion time (2.7  1.4 dB at 30 min vs. 2.6 
0.7 dB at 180 min for A parameter, 0.12  0.01 s1 vs.
0.11  0.02 s1 for b parameter). Thus, 50% reductions of
A and b in the RA during reperfusion were associated with
a large final IA of 80% RA.
Finally, regression analysis of histologic IA sizes with A
and b parameters calculated at 180 min of reperfusion
demonstrated good correlation for both parameters (A
parameter: y  8.67x  5.94, r  0.75, and b parameter:
y  0.32x  0.23, r  0.71). These data demonstrate the
capability of FLASH sequence parameters to predict IA size
in the initial hours after reperfusion.
Reproducibility. Defect measurements and quantitative
parameters were evaluated by two observers for interob-
server variability. For all defect measurements, the variabil-
ity expressed by the relative mean error was 8.2% during
occlusion, whereas it was 12.4% during reperfusion. Similar
results were observed for quantitative parameters from
FLASH and LATE sequences during occlusion (FLASH
sequence: A parameter 10.5%, b parameter 7.2%; LATE
sequence: A parameter 8.3%) and reperfusion (FLASH se-
quence: A parameter 12.7%, b parameter 9.9%; LATE
sequence: A parameter 8.1%).
DISCUSSION
Although several studies have demonstrated the capacity of
low-energy real-time MCE to detect coronary stenosis
(3,5), no data exist regarding the ability of this technique to
assess acute coronary occlusion/reperfusion. We postulated
that the extent and time course of microbubble refilling
would distinguish normally perfused, collateral-dependent
and nonperfused myocardium, and therefore differentiate
RA from infarct zone associated with total coronary ob-
struction and reflow. The major findings of our study are as
follows: 1) the size of an opacification defect varies with the
time period available for microbubble refilling; 2) during
occlusion, 15-cardiac-cycle FLASH sequence imaging
yields a larger defect size, which correlates more closely with
RA than IA, whereas imaging delayed for at least 1 min
yields a smaller area of abnormal opacification that corre-
lates more closely with IA than RA; 3) neither b nor A
parameters from the FLASH sequence predict infarct size
during occlusion; 4) during reperfusion, opacification defect
size from a FLASH sequence can predict both RA (from
images of initial cardiac cycles) and IA (from images at the
end of the sequence); 5) both A and b parameters are
decreased in RA myocardium compared to baseline postre-
perfusion, with the decrease in b occurring earlier than A; 6)
50% decreases in A and b during early reperfusion occur
when infarct size is above 80% of RA; therefore, marked
reduction of A and b correspond to large IA; 7) the ability
of A and b parameters to predict IA after reperfusion
improved over time and was best at 180 min. These data
provide the basis for the clinical application of MCE to
assess RA and IA during acute coronary occlusion/
reperfusion in patients.
Risk and IA assessment during occlusion. Our major
finding was that MCE was able to quantitatively assess both
RA and IA during occlusion, but not from FLASH se-
quences alone. Thus, in the absence of antegrade flow,
perfusion defects in FLASH sequence images accurately
delineated RA. However, RA opacification increased pro-
gressively for 1 min after microbubble destruction, and 15
cardiac cycles were insufficient to detect the complete
opacification of this region. Therefore, a smaller defect was
visualized in LATE images and correlated more closely with
infarct size. These data indicate that MCE can detect slow
Figure 3. Correlations between risk area (RA) and infarct area (IA) sizes
obtained by postmortem dye methods and FLASH sequence defects
(beginning of the sequence, BEGIN) on the top panel and LATE
sequence defects (LATE) during occlusion: RA is most closely correlated
with BEGIN defect and IA most closely with LATE defect.
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collateral flow perfusing the RA and preventing the evolu-
tion of RA ischemia into infarction. Although previous
studies have shown a high correlation between the size of
MCE defects and RA (6,7), analysis of MCE refilling
images acquired early and late after FLASH bubble destruc-
tion is the only technique thus far shown to provide
information regarding both RA and IA during coronary
occlusion.
Risk and IA assessment during reperfusion. Based on the
same mechanism of microbubble refilling, MCE analysis
also enabled assessment of both RA and IA during reper-
fusion. Risk area was again delineated by absent opacifica-
tion in images at BEGIN, whereas IA was now depicted by
perfusion defects in images at the END as well as those
visualized at 1 to 2 min of refilling. Thus, in the case of
reperfusion, FLASH sequences alone can be used to assess
RA and IA, indicating that blood flow velocities are
generally homogeneous and that microbubbles refill the
myocardium within the 15 cardiac cycles following restora-
tion of flow. Moreover, as will be discussed, MBF abnor-
malities were identified by quantitative analysis of A and b
parameters from refilling curves during reperfusion.
The correlation with IA observed during reperfusion was
similar to that reported by Villanueva et al. (8) using
intraaortic contrast with adenosine. In the prior study,
correlations without adenosine were less than those ob-
served in our study. Several factors may explain these
differences: only fundamental grayscale imaging was avail-
able to Villanueva and the concentration of myocardial
microbubbles with intravenous injection of contrast agent is
lower than with intraaortic injection. However, MCE still
underestimated RA and IA areas in our study (Figs. 2 and
5), confirming the discrepancy between capillary integrity
and myocardial cell necrosis, which can be reduced by using
pharmacologically induced hyperemia. Moreover, real-time
MCE with power pulse inversion is still subject to the
“blooming” phenomenon.
Prior studies by us (9) and others (10) have found that
myocardium that is infarcted histologically or noncontractile
after revascularization may exhibit opacification by MCE.
Similar findings were observed in two of 11 experiments.
The greater frequency with which infarcted myocardium in
this study was observed to exhibit a perfusion defect by
MCE is again likely due to the low-energy real-time
Figure 4. Correlations between size of the infarct area (IA) and myocardial contrast echography (MCE) parameters from FLASH and LATE
sequence.
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imaging technique, intravenous injection and nature of the
microbubble agent employed, and may have implications for
the clinical setting.
Finally, the long interval required for RA opacification
seemed inconsistent with the velocity of collateral flow,
suggesting that some microbubble destruction may have
occurred. However, the discrepancy between defects ac-
quired during occlusion and reperfusion (smaller defect with
the FLASH sequence during the reperfusion) is most likely
due to an increase of collateral flow during reperfusion
combined with the addition of anterograde flow, which
improved microvascular flow to the viable areas of the
perfusion bed. This hypothesis is supported by the results of
Ambrioso et al. (11), who observed an increase of regional
MBF in both RA and CA compared to baseline and
ischemia stages.
Quantitative parameters from FLASH sequence. In the
current study we utilized microbubble destruction/refilling
curves derived from low-energy real-time MCE.
Electrocardiogram-gated approaches to quantify MCE re-
filling have also been developed and are available for clinical
application. Coggins et al. (12) recently demonstrated that
ECG-gated acquisition was able to analyze both RA and IA
by varying pulsing intervals. Recent studies in our laboratory
have also shown that the refilling parameters derived from
real-time and ECG-gated imaging sequences are similar.
Therefore, the MCE approach to assessing RA and infarct
size during coronary occlusion and reperfusion should be
applicable to both real-time and triggered MCE ap-
proaches.
We had hypothesized that quantitative parameters from
MCE refilling curves obtained during coronary occlusion
would predict ultimate infarct size. This clearly was not the
case. Rather, the contrast intensity recorded from the
perfusion bed during coronary artery occlusion appears
insufficient to accurately yield quantitative refilling param-
eters. However, quantitative measurements were able to
distinguish the occluded area from the reperfused area both
with A and b parameters (Fig. 6).
Analysis of our data indicated that quantitative parame-
ters derived from refilling curves during myocardial reper-
fusion could distinguish reperfused myocardium from that
which was unaffected by reduced coronary flow. Thus,
following reperfusion both A and b parameters were de-
creased in the RA as opposed to an adjacent CA. Never-
theless, TTC staining indicated that, in the absence of
profound (50% or greater) reduction in quantitative param-
eters, the myocardium exhibits viability. Therefore, assess-
ment of refilling MCE parameters from postreperfusion
myocardium may be of value in distinguishing RA from
normally perfused myocardium, and may be capable of
indicating areas of infarcted muscle by virtue of profound
reduction in magnitude.
The findings of this study indicated that quantitative
parameters of MCE refilling correlated best with ultimate
evidence of infarction when obtained 60 to 180 min
postreperfusion. These data suggest that, if this approach is
to be utilized clinically, assessment of infarction versus
viability by MCE should be delayed for at least 1 h
following the reestablishment of flow. Nevertheless, even
these data may be of value in patients initially undergoing
echocardiography some time after reperfusion therapy. It
Figure 5. Correlations between risk area (RA) and infarct area (IA) sizes obtained by postmortem dye methods and FLASH sequence defects (beginning
of the sequence, BEGIN, and end of the sequence, END, respectively) at four time points of reperfusion. MCE  myocardial contrast echocardiography.
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was somewhat surprising that a quantitative measurement of
the time course of contrast refilling derived from only a
portion of the RA should be predictive of the ultimate
percent of RA undergoing infarction. Rather, one would
have predicted that refilling parameters should be specific to
the area of myocardium from which they were derived. It is
likely that the predictive correlation between refilling pa-
rameters and the ratio of infarct size to RA observed in this
study may be due to an attempt to include intensity
measurements from as large a portion of the RA as possible.
Clinical implications. Our study provides a basis of the
application of MCE to myocardial infarction. We have
shown it is possible to both visualize and quantitatively
assess risk and IAs during coronary occlusion. Furthermore,
MCE can assess the efficacy of reperfusion treatment, which
may guide subsequent patient management, but is limited
by requiring 180 min to be most accurate. This experimental
study has also delineated cautions that must be observed
when using MCE. Specifically, the opacification defect
visualized is determined in large measure by the refilling
time at which images are obtained. It is therefore very
important to acquire both FLASH and LATE sequence
data so as not to miss any perfusion information. However,
this temporal variation provides the basis of distinguishing
RA from IA.
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